| Biological properties of extracellular vesicles and their physiological functions M Yáñez-Mó, PRM Siljander, Z Andreu, A Bedina Zavec, FE Borràs, ... Journal of extracellular vesicles 4 (1), 27066, 2015 | 5638 | 2015 |
| Cutting edge: role of Toll-like receptor 9 in CpG DNA-induced activation of human cells F Takeshita, CA Leifer, I Gursel, KJ Ishii, S Takeshita, M Gursel, ... The Journal of Immunology 167 (7), 3555-3558, 2001 | 796 | 2001 |
| Evidence-based clinical use of nanoscale extracellular vesicles in nanomedicine S Fais, L O’Driscoll, FE Borras, E Buzas, G Camussi, F Cappello, ... Perspective, 2016 | 487 | 2016 |
| Use of CpG oligodeoxynucleotides as immune adjuvants DM Klinman, D Currie, I Gursel, D Verthelyi Immunological reviews 199 (1), 201-216, 2004 | 421 | 2004 |
| Efficient production and enhanced tumor delivery of engineered extracellular vesicles DC Watson, D Bayik, A Srivatsan, C Bergamaschi, A Valentin, G Niu, ... Biomaterials 105, 195-205, 2016 | 368 | 2016 |
| Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation I Gursel, M Gursel, H Yamada, KJ Ishii, F Takeshita, DM Klinman The Journal of Immunology 171 (3), 1393-1400, 2003 | 320 | 2003 |
| Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide M Gürsel, D Verthelyi, I Gürsel, KJ Ishii, DM Klinman Journal of Leukocyte Biology 71 (5), 813-820, 2002 | 294 | 2002 |
| Antibiotic release from biodegradable PHBV microparticles D Sendil, I Gürsel, DL Wise, V Hasırcı Journal of Controlled Release 59 (2), 207-217, 1999 | 283 | 1999 |
| Sterically stabilized cationic liposomes improve the uptake and immunostimulatory activity of CpG oligonucleotides I Gursel, M Gursel, KJ Ishii, DM Klinman The Journal of Immunology 167 (6), 3324-3328, 2001 | 272 | 2001 |
| Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9 F Takeshita, I Gursel, KJ Ishii, K Suzuki, M Gursel, DM Klinman Seminars in immunology 16 (1), 17-22, 2004 | 250 | 2004 |
| In vivo application of biodegradable controlled antibiotic release systems for the treatment of implant-related osteomyelitis İ Gürsel, F Korkusuz, F Türesin, NG Alaeddinoǧlu, V Hasırcı Biomaterials 22 (1), 73-80, 2000 | 215 | 2000 |
| WITHDRAWN: Is global BCG vaccination coverage relevant to the progression of SARS-CoV-2 pandemic? M Gursel, I Gursel Medical Hypotheses, 109707, 2020 | 210 | 2020 |
| Biosorption of phenol and 2-chlorophenol by Funalia trogii pellets G Bayramoglu, I Gursel, Y Tunali, MY Arica Bioresource technology 100 (10), 2685-2691, 2009 | 177 | 2009 |
| Potential role of phosphatidylinositol 3 kinase, rather than DNA-dependent protein kinase, in CpG DNA–induced immune activation KJ Ishii, F Takeshita, I Gursel, M Gursel, J Conover, A Nussenzweig, ... The Journal of experimental medicine 196 (2), 269-274, 2002 | 174 | 2002 |
| Biodegradable polyhydroxyalkanoate implants for osteomyelitis therapy: in vitro antibiotic release F Türesin, I Gürsel, V Hasirci Journal of Biomaterials Science, Polymer Edition 12 (2), 195-207, 2001 | 167 | 2001 |
| Intestinal microbiota in patients with spinal cord injury B Gungor, E Adiguzel, I Gursel, B Yilmaz, M Gursel PloS one 11 (1), e0145878, 2016 | 163 | 2016 |
| Sulbactam‐cefoperazone polyhydroxybutyrate‐co‐ hydroxyvalerate (PHBV) local antibiotic delivery system: In vivo effectiveness and biocompatibility in the … MF Yagmurlu, F Korkusuz, I Gürsel, P Korkusuz, Ü Örs, V Hasirci Journal of Biomedical Materials Research: An Official Journal of The Society …, 1999 | 163 | 1999 |
| Effect of suppressive DNA on CpG-induced immune activation H Yamada, I Gursel, F Takeshita, J Conover, KJ Ishii, M Gursel, ... The Journal of Immunology 169 (10), 5590-5594, 2002 | 149 | 2002 |
| CpG oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccine H Xie, I Gursel, BE Ivins, M Singh, DT O'Hagan, JB Ulmer, DM Klinman Infection and immunity 73 (2), 828-833, 2005 | 139 | 2005 |
| Liposomes as immunological adjuvants and vaccine carriers G Gregoriadis, I Gursel, M Gursel, B McCormack Journal of Controlled Release 41 (1-2), 49-56, 1996 | 134 | 1996 |
Mayda GurselIzmir Biomedicine and Genome CenterE-mailová adresa ověřena na: ibg.edu.tr
